Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Microbiol.

Sec. Infectious Agents and Disease

Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1639187

Temporal Dynamics of SARS-CoV-2 Phylogenetic Diversity in Central Brazil Reveals Evolutionary Shifts Among Variants of Concern during the pandemic

Provisionally accepted
José Alexandre  Felizola Diniz-FilhoJosé Alexandre Felizola Diniz-Filho1*Rhewter  NunesRhewter Nunes2Cintia  TarguetaCintia Targueta3Ramilla  dos Santos Braga FerreiraRamilla dos Santos Braga Ferreira4Amanda  Melo Ximenes-AlvesAmanda Melo Ximenes-Alves3Renata  de Oliveira DiasRenata de Oliveira Dias3Juliana  Santana De CurcioJuliana Santana De Curcio3Daniela  De Melo E SilvaDaniela De Melo E Silva3Menira  Borges SouzaMenira Borges Souza3Fabiola  Souza FiaccadoriFabiola Souza Fiaccadori3Elisângela  de Paula LacerdaElisângela de Paula Lacerda3Cristiana  maria ToscanoCristiana maria Toscano3Thiago  Fernando RangelThiago Fernando Rangel3Mariana  P C TellesMariana P C Telles3,5
  • 1Universidade Federal de Goiás, Goiânia, Brazil
  • 2Universidade Estadual de Goias, Anápolis, Brazil
  • 3Universidade Federal de Goias, Goiânia, Brazil
  • 4Universidade Federal de Rondonopolis, Rondonópolis, Brazil
  • 5Pontificia Universidade Catolica de Goias, Goiânia, Brazil

The final, formatted version of the article will be published soon.

The COVID-19 pandemic has led to substantial health, economic, and social impacts worldwide, and now, after more than five years since the start of the pandemic, it is possible to retrospectively evaluate patterns of SARS-CoV-2 spread and its consequences. Here we investigate the temporal dynamics of SARS-CoV-2 phylogenetic diversity in Goiás State, Central Brazil, using genomic data from 8,937 viral sequences obtained from GISAID between March 2020 and October 2024. Phylogenetic diversity was assessed through median pairwise distances (MedPD) and phylogenetic eigenvector regression (PVR) derived from principal coordinate analysis (PCoA) of pairwise distances among sequences. Results show evolutionary shifts associated with the emergence of new variants of concern (VOCs), particularly Gamma and Omicron, corresponding to distinct peaks in phylogenetic diversity through time. The initial rise in MedPD coincided with the Gamma variant's emergence in early 2021, while a more pronounced peak followed the spread of the Omicron variant in late 2021. Although a third peak appeared in late 2023, it was based on smaller sample sizes and did not correspond to a major VOC. Moreover, the temporal dynamics of MedPD tends to mirror the epidemiological characterization of the epidemic over time, including morbidity and mortality, reflecting the impact of vaccination in the disease burden of subsequent variants. The strong phylogenetic signal over time, reflected in the first PCoA axis, highlights the evolutionary trajectory of the virus. This study illustrates how genomic surveillance provides critical insights into viral diversification and public health responses during pandemics.

Keywords: SARS-CoV2, Phylogenetic comparative analyses, Mean Pairwise Distances, Phylogenetic eigenvectors, GISAID, VOCs

Received: 01 Jun 2025; Accepted: 26 Jul 2025.

Copyright: © 2025 Diniz-Filho, Nunes, Targueta, Ferreira, Ximenes-Alves, Dias, De Curcio, Silva, Souza, Fiaccadori, Lacerda, Toscano, Rangel and Telles. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: José Alexandre Felizola Diniz-Filho, Universidade Federal de Goiás, Goiânia, Brazil

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.